Clinical Trial Update: A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating combining metformin with muraglitazar or pioglitazone in Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Muraglitazar (muraglitazar)
• PIOGLITAZONE (Pioglitazone)
• metformin (metformin)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED